UB Paderborn / Katalog / Suche / in CDI

1 – 23 von 23

Sortiert nach

Rosiglitazone prevents the onset of hyperglycaemia and proteinuria in the Zucker diabetic fatty rat

Diabetes, obesity & metabolism, 2000-12, Vol.2 (6), p.363-372

2000

Volltextzugriff (PDF)

Staphylococcal osteomyelitis—a comparison of co-amoxiclav with clindamycin and flucloxacillin in an experimental rat model

Journal of antimicrobial chemotherapy, 1994-11, Vol.34 (5), p.755-764

1994

Volltextzugriff (PDF)

Comparison of adipose tissue changes following administration of rosiglitazone in the dog and rat

Diabetes, obesity & metabolism, 2001-06, Vol.3 (3), p.163-170

2001

Volltextzugriff (PDF)

Potential benefit of inhibitors of advanced glycation end products in the progression of type II diabetes: A study with aminoguanidine in C57/BLKsJ diabetic mice

Metabolism, clinical and experimental, 1998-12, Vol.47 (12), p.1477-1480

1998

Volltextzugriff (PDF)

Effect of potent urease inhibitor, fluorofamide, on Helicobacter sp. in vivo and in vitro

Digestive diseases and sciences, 1998, Vol.43 (1), p.109-119

1998

Volltextzugriff (PDF)

Effect of probucol on serum lipids, atherosclerosis and toxicology in fat-fed LDL receptor deficient mice

Atherosclerosis, 1998-12, Vol.141 (2), p.237-247

1998

Volltextzugriff (PDF)

Neutropenia does not prevent etodolac- or indomethacin-induced gastrointestinal damage in the rat

Digestive diseases and sciences, 1995-12, Vol.40 (12), p.2694-2703

1995

Volltextzugriff (PDF)

Relevance of Chlamydia pneumoniae murine pneumonitis model to evaluation of antimicrobial agents

Antimicrobial Agents and Chemotherapy, 1995-09, Vol.39 (9), p.1959-1964

1995

Volltextzugriff (PDF)

Peroxisome proliferator-activated receptor-gamma agonist, rosiglitazone, protects against nephropathy and pancreatic islet abnormalities in Zucker fatty rats

Diabetes (New York, N.Y.), 1998-08, Vol.47 (8), p.1326

1998

Volltextzugriff (PDF)

Study of the effects of cardiovascular drugs in heart cell cultures

Toxicology in vitro, 1996-12, Vol.10 (6), p.765-773

1996

Volltextzugriff (PDF)

The lack of toxicity of potassium channel activators in heart cell cultures

Toxicology in vitro, 1998-02, Vol.12 (1), p.67-75

1998

Volltextzugriff (PDF)

Study of the cardiotoxic potential of pharmaceutical compounds in chick myocardial myocyte reaggregate cultures

THIRD INTERNATIONAL CONFERENCE ON PRACTICAL IN VITRO TOXICOLOGY, 1994-08, Vol.8 (4), p.543-544

1994

Volltextzugriff (PDF)

Nabumetone, in contrast to etodolac, lacks gastrointestinal irritancy in the rat: Assessment by the inflammatory marker, haptoglobin, and blood loss

Inflammopharmacology, 1995-09, Vol.3 (3), p.259-270

1995

Volltextzugriff (PDF)

Antiinflammatory and gastrointestinal effects of nabumetone or its active metabolite, 6-methoxy-2-napnhthylacetic acid (6MNA) : comparative studies with indomethacin

Digestive diseases and sciences, 1992, Vol.37 (12), p.1847-1852

1992

Volltextzugriff (PDF)

Nabumetone, an effective anti-inflammatory agent, lacks gastrointestinal irritancy in the rat when dosed orally for one month: comparison with tiaprofenic acid and etodolac

European journal of rheumatology and inflammation, 1994, Vol.14 (2), p.15

1994

Volltextzugriff (PDF)

Studies on the uptake and accumulation of heavy metals by the brown shrimp crangon vulgaris (fabricius)

Toseland, C D. N

1979

Volltextzugriff (PDF)

Anti-inflammatory and gastrointestinal effects of nabumetone or its active metabolite, 6MNA (6-methoxy-2-naphthylacetic acid): Comparison with indomethacin

Agents and Actions, 1992-03, Vol.36 (S1), p.C82-C83

1992

Volltextzugriff (PDF)

Anti-inflammatory and gastrointestinal effects of nabumetone or its active metabolite, 6MNA (6-methoxy-2-naphthylacetic acid): Comparison with indomethacin

Agents and Actions, 1992-07, Vol.36 (3-4), p.C82-C83

1992

Volltextzugriff (PDF)

The biogeographic differentiation of algal microbiomes in the upper ocean from pole to pole

Nature communications, 2021-09, Vol.12 (1), p.5483-15, Article 5483

2021

Volltextzugriff (PDF)

Rapid reversal of hepatic steatosis, and reduction of muscle triglyceride, by rosiglitazone: MRI/S studies in Zucker fatty rats

Diabetes, obesity & metabolism, 2003-07, Vol.5 (4), p.234-243

2003

Volltextzugriff (PDF)

Acceleration of the development of diabetes in obese diabetic (db/db) mice by nicotinamide : A comparison with its antidiabetic effects in non-obese diabetic mice

Metabolism, clinical and experimental, 2000-12, Vol.49 (12), p.1548-1554

2000

Volltextzugriff (PDF)

An audit of Therapeutic Drug monitoring service provision by laboratories participating in an External Quality assessment scheme

Therapeutic drug monitoring, 1998-06, Vol.20 (3), p.248-252

1998

Volltextzugriff (PDF)

Levels of anticonvulsive drugs in biological fluids. Problems involved with their administration

Therapie, 1973-09, Vol.28 (5), p.993

Toseland, P A

1973

Volltextzugriff (PDF)

1 – 23 von 23

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(18)
Mit Volltextzugriff
(19)

Publikationsform

Artikel
(22)
Dissertationen
(1)

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(15)
Biological And Medical Sciences
(14)
Life Sciences & Biomedicine
(14)
Medical Sciences
(14)
Animals
(12)
Pharmacology. Drug Treatments
(10)
Male
(9)
Drug Toxicity And Drugs Side Effects Treatment
(7)
Rats
(7)
Female
(6)
Endocrinology & Metabolism
(5)
Toxicology
(5)
Mice
(4)
Rosiglitazone
(4)
Thiazolidinediones
(4)
Toxicity: Cardiovascular System
(4)
Hypoglycemic Agents - Therapeutic Use
(3)
Pancreas - Pathology
(3)
Pharmacology & Pharmacy
(3)
Thiazoles - Therapeutic Use
(3)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Rosiglitazone prevents the onset of hyperglycaemia and proteinuria in the Zucker diabetic fatty rat

Staphylococcal osteomyelitis—a comparison of co-amoxiclav with clindamycin and flucloxacillin in an experimental rat model

Comparison of adipose tissue changes following administration of rosiglitazone in the dog and rat

Potential benefit of inhibitors of advanced glycation end products in the progression of type II diabetes: A study with aminoguanidine in C57/BLKsJ diabetic mice

Effect of potent urease inhibitor, fluorofamide, on Helicobacter sp. in vivo and in vitro

Effect of probucol on serum lipids, atherosclerosis and toxicology in fat-fed LDL receptor deficient mice

Neutropenia does not prevent etodolac- or indomethacin-induced gastrointestinal damage in the rat

Relevance of Chlamydia pneumoniae murine pneumonitis model to evaluation of antimicrobial agents

Peroxisome proliferator-activated receptor-gamma agonist, rosiglitazone, protects against nephropathy and pancreatic islet abnormalities in Zucker fatty rats

Study of the effects of cardiovascular drugs in heart cell cultures

The lack of toxicity of potassium channel activators in heart cell cultures

Study of the cardiotoxic potential of pharmaceutical compounds in chick myocardial myocyte reaggregate cultures

Nabumetone, in contrast to etodolac, lacks gastrointestinal irritancy in the rat: Assessment by the inflammatory marker, haptoglobin, and blood loss

Antiinflammatory and gastrointestinal effects of nabumetone or its active metabolite, 6-methoxy-2-napnhthylacetic acid (6MNA) : comparative studies with indomethacin

Nabumetone, an effective anti-inflammatory agent, lacks gastrointestinal irritancy in the rat when dosed orally for one month: comparison with tiaprofenic acid and etodolac

Studies on the uptake and accumulation of heavy metals by the brown shrimp crangon vulgaris (fabricius)

Anti-inflammatory and gastrointestinal effects of nabumetone or its active metabolite, 6MNA (6-methoxy-2-naphthylacetic acid): Comparison with indomethacin

Anti-inflammatory and gastrointestinal effects of nabumetone or its active metabolite, 6MNA (6-methoxy-2-naphthylacetic acid): Comparison with indomethacin

The biogeographic differentiation of algal microbiomes in the upper ocean from pole to pole

Rapid reversal of hepatic steatosis, and reduction of muscle triglyceride, by rosiglitazone: MRI/S studies in Zucker fatty rats

Acceleration of the development of diabetes in obese diabetic (db/db) mice by nicotinamide : A comparison with its antidiabetic effects in non-obese diabetic mice

An audit of Therapeutic Drug monitoring service provision by laboratories participating in an External Quality assessment scheme

Levels of anticonvulsive drugs in biological fluids. Problems involved with their administration

Suchergebnisse filtern